These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils. Hsieh SC; Yu HS; Cheng SH; Li KJ; Lu MC; Wu CH; Tsai CY; Yu CL Clin Rheumatol; 2007 Feb; 26(2):216-24. PubMed ID: 16575489 [TBL] [Abstract][Full Text] [Related]
37. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates. Korkmaz B; Attucci S; Hazouard E; Ferrandiere M; Jourdan ML; Brillard-Bourdet M; Juliano L; Gauthier F J Biol Chem; 2002 Oct; 277(42):39074-81. PubMed ID: 12114510 [TBL] [Abstract][Full Text] [Related]
38. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. Uehara A; Sugawara S; Muramoto K; Takada H J Immunol; 2002 Oct; 169(8):4594-603. PubMed ID: 12370398 [TBL] [Abstract][Full Text] [Related]
39. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate. Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715 [TBL] [Abstract][Full Text] [Related]
40. Different forms of alpha-1 antitrypsin and neutrophil activation mediated by human anti-PR3 IgG antibodies. Surmiak M; Sanak M Pharmacol Rep; 2016 Dec; 68(6):1276-1284. PubMed ID: 27689755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]